Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors as opposed to. Dipeptidyl Peptidase-4 (DPP4) Inhibitors pertaining to New-Onset Dementia: A Propensity Score-Matched Population-Based Study Using Contending Chance Investigation.